基因工程抗体anti-HBsAgFab原核表达体系大规模培养条件的实验研究

南方医科大学学报 ›› 2004, Vol. 24 ›› Issue (05): 517-520.

基因工程抗体anti-HBsAgFab原核表达体系大规模培养条件的实验研究

郑大勇¹, 罗荣城¹, 蔡红兵²

1. 第一军医大学, 南方医院肿瘤科, 广东, 广州, 510515;
2. 第一军医大学, 中医系, 广东, 广州, 510515

出版日期:2004-05-20 发布日期:2004-05-20
基金资助:
收稿日期:2003-10-21。
基金项目:国家自然科学基金(39670668)
作者简介:郑大勇(1976- ),男,第一军医大学在读博士研究生,电话:020-61641651-811,E-mail:zhengdayong@hotmail.com

Conditions for large-scale production of genetically engineered E.coli bearing humanized anti- HBsAg Fab

ZHENG Da-yong¹, LUO Rong-cheng¹, CAI Hong-bin²

1. 第一军医大学, 南方医院肿瘤科, 广东, 广州, 510515;
2. 第一军医大学, 中医系, 广东, 广州, 510515

Online:2004-05-20 Published:2004-05-20

摘要/Abstract

摘要： 目的探讨含anti-HBsAg Fab/pBAD表达载体的工程化大肠杆菌的大规模培养条件。方法在摇瓶发酵条件下探讨工程菌的生长和表达规律,摸索最佳的培养模式及诱导表达条件。后根据摇瓶发酵结果于发酵罐中行补料高密度发酵试验,确定最佳补料模式。结果由摇瓶发酵获得的数据表明,以培养体系处于对数生长中期为诱导表达的起点、在25 ℃条件下以0.2% 阿拉伯糖诱导12 h,Fab的得率最佳,采用溶氧控制补料模式可使培养体系的最大D₆₀₀达到55.2,相当于湿菌含量110 g/L水平;同时,经证实Fab的抗原结合活性良好。结论初步确定了周期短、产率高且稳定可靠的发酵工艺路线,为应用原核表达体系工业化大批量生产基因工程抗体奠定了基础。

Abstract: Objective To define the conditions for large-scale production of genetically engineered E.coli bearing humanized anti-HBsAg Fab. Method Characteristic growth and expression of the engineered E.coli were observed during fermentation in the shaking flask to define the optimal culture conditions to achieve the highest production levels. On the basis of the observation results, the E.coli was cultured in a fermentor using the fed-batch method to determine the optimal production techniques. Results Observation of the bacterium in the shaking flask showed initiation of the induction procedure in the mid-log growth phase at 25 ℃ with 0.2% arabinose resulted in the highest production of anti-HBsAg Fab. The D₆₀₀ value of the culture reached 55.2, equivalent to 110 g/L wet weight of the bacterium, using the DO-stat fed-batch method. The resultant Fab showed well-preserved biological activity. Conclusion Reliable techniques for rapid and massive production of the Fab have been developed.

中图分类号:

R392.11

郑大勇¹, 罗荣城¹, 蔡红兵². 基因工程抗体anti-HBsAgFab原核表达体系大规模培养条件的实验研究[J]. 南方医科大学学报, 2004, 24(05): 517-520.

ZHENG Da-yong¹, LUO Rong-cheng¹, CAI Hong-bin². Conditions for large-scale production of genetically engineered E.coli bearing humanized anti- HBsAg Fab[J]. Journal of Southern Medical University, 2004, 24(05): 517-520.

参考文献

[1] Lee SY. High cell-density culture ofEscherichia coli [J]. Trends Biotechnol, 1996, 14(3): 98-105.
[2] Makrides SC. Strategies for achieving high-level expression of genes in Escherichia coli[J]. Microbiol Rev, 1996, 60(3): 512-38.
[3] 李仲宏,麦国丰,罗荣城,等.瘤内注射核素标记混合抗体治疗肝癌的实验研究[J].第一军医大学学报,2000,20(4):327-8.Li ZH, Mai GF, Luo RC, et al. Experimental studies of treatment of the liver cancer by intratumoral injection of 131I-labeled multiple monoclonal antibodies [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2000, 20(4): 327-8.
[4] 罗荣城,尤长宣,韩焕兴,等.人源乙型肝炎病毒表面抗原抗体Fab片段与IFN-α融合蛋白表达载体的筛选[J].第一军医大学学报,2000,20(2):100-3.Luo RC, You CX, Han HX, et al. Selection of the expression vector for the fusion protein of human anti-HBs antibody Fab fragment and interferon-α [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2000, 20(2): 100-3.
[5] Riesenberg D, Menzel K, Schulz V, et al. High-cell density fermentation of recombinant Escherichia coli. Expressing human interferon alpha[J]. Appl Microbio Biotechnol, 34(1): 77-82.
[6] Pluckthun A, Krebber A. Producing antibodies in Escherichia coli:from PCR to fermentation [A]. In: McCaffergy J, Hoogenboon H,Chiswell D, eds. Antibody Engineering: A Practical Approach [M].Oxford: Oxford University Press, 2001. 203-52.
[7] Luli GW, Strohl WR. Comparison of growth, acetate, production and acetate inhibition of Escherichia coli. Strains in batch and fedbatch fermentation[J]. Appl Environ Microbiol, 1990, 56(4): 1004-11.
[8] Guzman LM, Belin D, Carso MJ, et al. Tight regulation, modulation,and high-level expression by vectors containing the arabinose pBAD promoter[J]. J Bacteriol, 177(54): 4121-30.
[9] Horn V, Strittmatter W. High volumetric yields of functional dimeric miniantibodies in Escherichia coli. Using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions[J]. Appl Microbiol Biotechnol, 46(3): 524-32.
[10] Clark MA, Hammond FR, Papaioannou A, et al. Regulation and expression of human Fab under the control of the Escherichia coli arabinose promoter, pBAD [J]. Immunotechnology, 1997, 3 (3): 217-26.